Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1967648, 7 pages
https://doi.org/10.1155/2017/1967648
Research Article

MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection

1Department of Hematology, The First Hospital of Jilin University, Changchun 130021, China
2Department of Pediatrics, Women and Children’s Hospital of Qingdao University, Qingdao 266000, China
3Department of Pathology Diagnosis Center, The First Hospital of Jilin University, Changchun 130021, China

Correspondence should be addressed to Ou Bai; moc.361@61iabuo

Received 2 August 2017; Revised 21 September 2017; Accepted 3 October 2017; Published 25 October 2017

Academic Editor: Carlo Visco

Copyright © 2017 Zhihe Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. h. Zhong, X. Liu, X. Bing, and Z. Za, Chinese Medical Association, the guideline of Prevention and Treatment for Chronic Hepatitis B, vol. 32, Chinese Society of Hepatology and Chinese Society of Infectious Diseases, 2010.
  2. C. W. Shepard, E. P. Simard, L. Finelli, A. E. Fiore, and B. P. Bell, “Hepatitis B virus infection: epidemiology and vaccination,” Epidemiologic Reviews, vol. 28, no. 1, pp. 112–125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Schweitzer, J. Horn, R. T. Mikolajczyk, G. Krause, and J. J. Ott, “Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013,” The Lancet, vol. 386, no. 10003, pp. 1546–1555, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. G.-L. Xia, C.-B. Liu, H.-L. Cao et al., “Prevalence of hepatitis B and C virus infections in the general Chinese population. results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992,” International Hepatology Communications, vol. 5, no. 1, pp. 62–73, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Dalia, J. Chavez, J. J. Castillo, and L. Sokol, “Hepatitis B infection increases the risk of non-Hodgkin lymphoma: A meta-analysis of observational studies,” Leukemia Research, vol. 37, no. 9, pp. 1107–1115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Taborelli, J. Polesel, M. Montella et al., “Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: A case-control study in Italy,” Infectious Agents and Cancer, vol. 11, no. 1, article no. 27, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Nath, R. Agarwal, P. Malhotra, and S. Varma, “Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis,” Internal Medicine Journal, vol. 40, no. 9, pp. 633–641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Deng, Y. Song, K. H. Young et al., “Hepatitis B virus-associated diffuse large B-cell lymphoma: Unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin,” Oncotarget , vol. 6, no. 28, pp. 25061–25075, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Guo, W. Zhang, C. Liu, Y. Song, and O. Bai, “Clinical analysis of the HBV infection status of 135 patients with diffuse large B cell lymphoma treated with R-CHOP or CHOP/CHOP-like chemotherapy,” PLoS ONE, vol. 10, no. 6, Article ID e0129064, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Norris and J. Stone, WHO classification of tumours of haematopoietic and lymphoid tissues, 2008.
  11. B. D. Cheson, B. Pfistner, M. E. Juweid et al., “Revised response criteria for malignant lymphoma,” Journal of Clinical Oncology, vol. 25, no. 5, pp. 579–586, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Reber, Y. Banz, E. Garamvölgyi, A. Perren, and U. Novak, “Determination of the molecular subtypes of diffuse large B-cell lymphomas using immunohistochemistry: a case series from the Inselspital, Bern, and a critical appraisal of this determination in Switzerland.,” Swiss Medical Weekly, vol. 143, p. w13748, 2013. View at Google Scholar · View at Scopus
  13. H. A. Poirel, M. S. Cairo, N. A. Heerema et al., “Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study,” Leukemia, vol. 23, no. 2, pp. 323–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. K. J. Savage, N. A. Johnson, S. Ben-Neriah et al., “MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy,” Blood, vol. 114, no. 17, pp. 3533–3537, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. G. Tibiletti, V. Martin, B. Bernasconi et al., “BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome,” Human Pathology, vol. 40, no. 5, pp. 645–652, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Shipp, D. Harrington, and J. Anderson, “A predictive model for aggressive non-Hodgkin's lymphoma. the international Non-Hodgkin's Lymphoma Prognostic Factors Project,” The New England Journal of Medicine, vol. 329, no. 14, pp. 987–994, 1993. View at Publisher · View at Google Scholar
  17. J. Wen, J. Zhou, Z. Liu, T. Liu, and C. Xu, “Analysis of survival and prognosis in 409 newly diagnosed patients with diffuse large B-cell lymphoma,” Chinese Journal of Hematology, vol. 35, no. 4, pp. 318–324, 2014. View at Google Scholar
  18. X. Li, Z. Liu, J. Cao et al., “Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: A 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group,” Annals of Hematology, vol. 91, no. 6, pp. 837–845, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Pfreundschuh, E. Kuhnt, L. Trümper et al., “CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group,” The Lancet Oncology, vol. 12, no. 11, pp. 1013–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Kojima, H. Nishikii, J. Takizawa et al., “MYC rearrangements are useful for predicting outcomes following rituximab and chemotherapy: Multicenter analysis of Japanese patients with diffuse large B-cell lymphoma,” Leukemia & Lymphoma, vol. 54, no. 10, pp. 2149–2154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. M. Aukema, M. Kreuz, C. W. Kohler et al., “Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma,” Haematologica, vol. 99, no. 4, pp. 726–735, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Tzankov, Z. Y. Xu-Monette, M. Gerhard et al., “Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP,” Modern Pathology, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. L. Barrans, P. A. S. Evans, S. J. M. O'Connor et al., “The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome,” Clinical Cancer Research, vol. 9, no. 6, pp. 2133–2139, 2003. View at Google Scholar · View at Scopus
  24. C. Kawasaki, K. Ohshima, J. Suzumiya et al., “Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas,” Leukemia & Lymphoma, vol. 42, no. 5, pp. 1099–1106, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Fujimoto, Y. Ishizaka, T. Tahira et al., “Possible involvement of c‐myc but not ras genes in hepatocellular carcinomas developing after spontaneous hepatitis in LEC rats,” Molecular Carcinogenesis, vol. 4, no. 4, pp. 269–274, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. V. E. Karev, “Fas, FasL, and bcl-2 expression on hepatic intralobar lymphocytes in different variants of the natural course of chronic HBV and HCV infection and in its outcomes,” Arkhiv Patologii, vol. 76, no. 1, pp. 16–21, 2014. View at Google Scholar · View at Scopus